You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedeXciteOSA® analisi dell'app per 15 gennaio
eXciteOSA®
- Signifier Medical Technologies Limited
- App Store di Apple
- Gratis
- Settore Medico
eXciteOSA® is the only daytime solution clinically proven to treat the root cause of mild obstructive sleep apnea (OSA) and snoring, rather than simply relieve the symptoms. The device only needs to be worn for twenty minutes a day, once a day, for six weeks, and twice a week thereafter.
eXciteOSA® improves the muscle function of the tongue through painless stimulation therapy. Improving these muscles prevents the upper airway tissue from collapsing and trains the upper airway to remain open during sleep, thereby improving sleep quality.
The eXciteOSA® app connects to the device via Bluetooth to activate and customize each therapy session. The app conveniently tracks your progress, keeps you focused on therapy goals, and shares valuable sleep tips with you along the way.
Let’s begin your journey towards better sleep. Download the app today.
The eXciteOSA device is available in the following countries: United States, UK, Canada, European Union countries, and Australia.
Classifica degli store
La classifica del store si basa su diversi parametri stabiliti da Google e Apple.
Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci
eXciteOSA®Statistiche di ranking nel tempo
Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per eXciteOSA®
Rank
Nessun dato disponibile
eXciteOSA® Classifica per paese
Paesi in cui eXciteOSA® ha la posizione più alta nelle sue categorie principali
Nessun dato da visualizzare
Principali concorrenti e app alternative
App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.
iNAP Lab+
Somnics, Inc.
Somnologs
ADRIEN DELANNOY
Empower Sleep
Empower Sleep Inc
Sonu
Sound Health Systems, Inc.
gennaio 15, 2026